Article Text

PDF

Treatment of resistant pain in hypertrophic pulmonary arthropathy with ketorolac.
  1. N Blackwell,
  2. L Bangham,
  3. M Hughes,
  4. D Melzack,
  5. I Trotman
  1. Mount Vernon Hospital, Northwood, Middlesex.

    Abstract

    Pain associated with hypertrophic pulmonary osteoarthropathy (HPOA) may be extremely disabling and resistant to treatment. The successful use of ketorolac, a new non-steroidal anti-inflammatory drug, given by subcutaneous infusion is reported in two patients with uncontrolled pain caused by HPOA.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.